Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,000 | 7,330 | 9,070 | 10,700 | 12,450 |
| Other current assets | 190 | 210 | 150 | 120 | 70 |
| TOTAL | $6,190 | $7,540 | $9,220 | $10,820 | $12,520 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 260 | 230 | 200 | 170 | 200 |
| TOTAL | $260 | $230 | $200 | $170 | $200 |
| Total Assets | $6,550 | $7,880 | $9,520 | $11,110 | $12,820 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 160 | 240 | 360 | 200 | 340 |
| Accrued Expenses | 1,060 | 630 | 450 | 790 | 260 |
| Other current liabilities | 0 | 3 | 4 | 0 | 0 |
| TOTAL | $1,220 | $880 | $820 | $1,000 | $600 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,220 | $880 | $820 | $1,000 | $600 |
| Shareholders' Equity | |||||
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | -24,680 | -23,000 | -21,300 | -19,880 | -17,720 |
| TOTAL | $5,320 | $7,000 | $8,700 | $10,100 | $12,220 |
| Total Liabilities And Equity | $6,540 | $7,880 | $9,520 | $11,100 | $12,820 |